Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease New
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Direct Oral Anticoagulants Versus Warfarin for Preventing Stroke and Systemic Embolic Events Among Atrial Fibrillation Patients With Chronic Kidney Disease New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease_New. Accessed 02 February 2023.
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease_New. Accessed February 2, 2023.
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease_New
Direct Oral Anticoagulants Versus Warfarin for Preventing Stroke and Systemic Embolic Events Among Atrial Fibrillation Patients With Chronic Kidney Disease New [Internet]. In: Cochrane Abstracts. [cited 2023 February 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease New
ID - 433620
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -